COV — Covalon Technologies Share News
0.000.00%
Last trade - 00:00- CA$59.66m
- CA$44.86m
- CA$32.82m
Brief: Covalon Announces New Antimicrobial Technology Formulated To Kill The Covid-19 Virus
Brief: Covalon Announces Re-Pricing Of Private Placement
Brief: Covalon Technologies Posts Q3 Loss Per Share of C$0.16
Brief: Covalon Announces Private Placement Of Up To $6.3 Million
Brief: Covalon Technologies Q2 Revenue Rises 132% To C$13.3 Mln
Brief: Covalon Announces First Quarter Fiscal 2019 Results
Brief: Dr. Myrna Francis joins Covalon’S board of directors
Brief: Covalon Announces Change Of Auditors And Amends And Restates Its Rolling Stock Option Plan
Brief: Covalon Announces Fiscal 2018 Year-End Results And Plans For Fiscal 2019
Brief: Covalon To Acquire Aquaguard And Its Salesforce Throughout U.S.
Brief: Covalon Technologies Q3 Earnings Per Share C$0.10
Brief: Covalon Announces Retirement Of Member Of Board Of Directors
Brief: Covalon Technologies Reports Qtrly Revenue Of $5.7 Mln, Qtrly Net Loss Of $479,082
Brief: Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Mln Over a Three-Year Period
Brief: Covalon Q1 Earnings Per Share C$0.02
Brief: Covalon Says Qtrly Total Revenue Increased 1,027% To $9.8 Mln
Brief: Covalon Q3 earnings per share C$0.02
Brief: Covalon posts record first quarter financial results
Brief: Covalon CEO provides update on anticipated fiscal 2017 financial growth